07/25/2026
BPC-157: FDA Approved? Not exactly. Here’s what changed. 👇
The FDA has NOT approved BPC-157 as a drug.
However, the FDA’s Pharmacy Compounding Advisory Committee (PCAC) recently voted to recommend adding BPC-157 to the list of substances that may be eligible for pharmacy compounding under certain conditions. This is an important regulatory step—but it is not the same as FDA approval. The FDA still has to make the final decision.
Key takeaway:
✔️ Not FDA-approved as a medication
✔️ Advisory committee voted in favor of compounding eligibility
✔️ Final FDA action is still pending
✔️ More clinical research is still needed to establish safety and efficacy for many proposed uses
At Dr. Ernai Academy, our mission is to help healthcare professionals understand the science, regulations, and evidence behind emerging therapies—not just the headlines.
Education. Evidence. Innovation.